Suppr超能文献

[尾加压素II对正常灌注及缺血再灌注大鼠离体心脏的影响]

[Effects of urotensin II on isolated rat hearts under normal perfusion and ischemia reperfusion].

作者信息

Zhou Ping, Wu Sheng-Ying, Yu Cheng-Fan, Wang Hua, Tang Chao-Shu, Lin Li, Yuan Wen-Jun

机构信息

Cardiovascular Institute, First Hospital, Peking University, Beijing 100034.

出版信息

Sheng Li Xue Bao. 2003 Aug 25;55(4):442-8.

Abstract

To shed light on cardiac effects of the potent vasoconstrictive peptide urotensin II (U II), Langendorff-perfused isolated rat hearts were consecutively perfused with 0.1, 1 and 10 nmol/L U II, for 5 min at each dose, followed by 5-min washout. Moreover, isolated hearts subjected to 20-min global no-flow ischemia were reperfused with U II (1 or 10 nmol/L) for 20 min. Heart function parameters including heart rate, left ventricular pressure and dP/dt were monitored; content of protein and myoglobin, and activity of lactate dehydrogenase (LDH) in coronary effluent were determined; malondialdehyde (MDA) in myocardium and [(125)I]-U II binding sites in plasma membrane were measured after the completion of perfusion. The results showed that: (1) In normal rat hearts, the coronary flow was decreased and the heart function was suppressed by U II dose-dependently, and these changes were not abolished by washout. The leakage of cardiac protein, myoglobin and LDH increased with the increment of U II, but it diminished rapidly after washout. In contrast, MDA content in U II -treated myocardium was not statistically different from that in normal myocardium. (2) Ischemia-reperfusion caused significant decreases in coronary flow, suppression of heart function, and leakage of protein and LDH. In U II -reperfused hearts, all these disorders were significantly aggravated and myocardial MDA content significantly increased (P<0.01), to a greater extent in the presence of higher dose of U II. (3) The maximal binding capacity (B(max)) of U II receptors in plasma membrane from ischemia-reperfusion myocardium increased significantly as compared with that of normal myocardium (20.53+/-1.98 vs 14.65+/-1.78 fmol/mg pr, P<0.01), while Kd remained unchanged. These results indicate that U II caused injury to the isolated rat hearts under normal perfusion, and worsened the injury of the hearts under ischemia-reperfusion, in which U II receptors were up-regulated.

摘要

为了阐明强效血管收缩肽尾加压素II(U II)对心脏的影响,采用Langendorff灌流法对离体大鼠心脏进行实验,依次用0.1、1和10 nmol/L的U II灌流,每个剂量灌流5分钟,随后冲洗5分钟。此外,对经历20分钟全心无血流缺血的离体心脏用U II(1或10 nmol/L)再灌注20分钟。监测包括心率、左心室压力和dP/dt在内的心脏功能参数;测定冠状动脉流出液中蛋白质、肌红蛋白含量以及乳酸脱氢酶(LDH)活性;灌注结束后测定心肌中丙二醛(MDA)含量以及质膜中[(125)I]-U II结合位点。结果显示:(1)在正常大鼠心脏中,U II可使冠状动脉血流量减少,心脏功能受到剂量依赖性抑制,冲洗后这些变化并未消除。心脏蛋白质、肌红蛋白和LDH的漏出量随U II浓度增加而增加,但冲洗后迅速减少。相比之下,U II处理的心肌中MDA含量与正常心肌无统计学差异。(2)缺血再灌注导致冠状动脉血流量显著减少、心脏功能受抑制以及蛋白质和LDH漏出。在U II再灌注的心脏中,所有这些紊乱均显著加重,心肌MDA含量显著增加(P<0.01),且高剂量U II时增加幅度更大。(3)与正常心肌相比,缺血再灌注心肌质膜中U II受体的最大结合容量(B(max))显著增加(20.53±1.98对14.65±1.78 fmol/mg pr,P<0.01),而解离常数(Kd)保持不变。这些结果表明,U II在正常灌注下可导致离体大鼠心脏损伤,并加重缺血再灌注时心脏的损伤,其中U II受体上调。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验